Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.
Scholarly Work
Search peer-reviewed articles, reports, books, policy briefs and other scholarly outputs by KIU researchers and collaborators.
2026 | F1000Research | Pp. 1-43
Background Benign prostatic hyperplasia [BPH] is a prevalent condition among aging men, characterized by prostate gland enlargement leading to lower urinary tract symptoms [LUTS]. Conventional treatments like alpha-blockers and 5-alpha-reductase inhibitors, t...
2026 | Biochemistry and Biophysics Reports | Pp. 1-13
Background: Medicinal plants produce specialised (secondary) metabolites including alkaloids, terpenoids, flavonoids and phenolics that underpin pharmaceuticals, nutraceuticals and traditional therapeutics. Although enzyme-encoding genes and transcription fac...
2026 | Frontiers in Soil Science | Pp. 1-11
Background: Polyphenols from root exudates and polyphenol-rich organic inputs may shape soil microbiomes, enzyme activities, and crop nutrient outcomes, with relevance to regenerative agriculture. Objectives: To quantify the effects of plant- and soil-derived...
2026 | Current Microbiology | Pp. 1-19
The gut microbiome supports digestion, immunity, and metabolism; its imbalance (dysbiosis) drives inflammation and metabolic dysfunction, contributing to chronic diseases such as diabetes, cardiovascular disease, inflammatory bowel disease, and autoimmune dis...
2026 | Sage | Pp. 1-11
Abstract1,3, and Plants are dynamic, responsive systems capable of perceiving, integrating, and transmitting information across multiple scales, from molecular pathways within cells to complex interactions at the community level. Emerging evidence demonstrate...
2026 | Frontiers in Food Science and Technology | Pp. 1-18
Hybrid digital twins (DTs) are emerging as decision-support systems for perishable food supply chains because they can transform shipment-specific exposure histories into individualized forecasts of quality evolution, safety risk, and remaining shelf-life (RS...
2026 | Obesity Medicine | Pp. 1-23
Obesity is a significant health issue worldwide, and a key risk factor for type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), non-alcoholic fatty liver disease (NAFLD), and related complications. Incretin-based therapies, especially glucagon-like...
2026 | Phytomedicine Plus | Pp. 1-13
Background/problem statement: Single-target pharmaceutical treatments generally fail to address the complex pathophysiology of chronic illnesses such as cancer, cardiovascular disorders, diabetes, and neurodegeneration. These conditions are prone to medicatio...
2026 | Dove Press | Pp. 1-21
Abstract: Multiple sclerosis (MS) is a chronic autoimmune disorder of CNS with demyelination, neurodegeneration and compartmentalized inflammatory disorder. Excessive T-helper cell (CD4+) activation and unregulated cytokine signaling play a key role in its on...
2026 | Discover Nano | Pp. 1-31
Background Reactive oxygen species (ROS) are key regulators of cellular signalling and homeostasis, but if not managed, they can cause genomic instability, activation of carcinogenic pathways, and chronic inflammation. Approaches to ROS regulation using nanot...